The silent epidemic of substandard and falsified medicines in low- and middle-income countries: heed lessons from the tragic deaths of children in Indonesia
Int J Surg
.
2023 Mar 1;109(3):523-525.
doi: 10.1097/JS9.0000000000000059.
Authors
ArunSundar MohanaSundaram
1
,
Bijaya K Padhi
2
,
Aroop Mohanty
3
,
Sunil Shrestha
4
,
Ranjit Sah
5
6
7
Affiliations
1
School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu.
2
Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh.
3
Department of Microbiology, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
4
School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Selangor, Malaysia.
5
Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
6
Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
7
Harvard Medical School, Boston, Massachusetts, USA.
PMID:
36906790
PMCID:
PMC10389216
DOI:
10.1097/JS9.0000000000000059
No abstract available
MeSH terms
Child
Counterfeit Drugs*
Developing Countries
Humans
Indonesia
Substances
Counterfeit Drugs